Prevention of Postpartum Anxiety in High-Risk Women
Postpartum Anxiety
About this trial
This is an interventional prevention trial for Postpartum Anxiety
Eligibility Criteria
Inclusion Criteria: Pregnant women (up to 30 weeks pregnant to allow for completion of the CBT-IU protocol before child delivery) 18 years or older Baseline score of ≥64 on the IUS (Furtado et al., 2021) No psychotropic medication or, if taking medication, no change in dose or type for a minimum of 6 weeks prior to baseline No concurrent psychological treatment Fluent in English and able to consent for treatment Located in Ontario, Canada Exclusion Criteria: A current diagnosed DSM-5 anxiety disorder, as assessed by the Mini International Neuropsychiatric Interview (version 7.0.2) Active suicidal ideation Current psychosis or substance use disorder For those enrolled on a stable dosage of a psychotropic medication, if a change in medication is required during the psychological therapy trial, the participant will continue with the therapy but will be excluded from the analysis.
Sites / Locations
- St. Joseph's Healthcare HamiltonRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Cognitive Behavioural Therapy
Treatment as Usual